Institutional investors purchased a net $860.9 thousand shares of AMPH during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 63.77% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PORTOLAN CAPITAL MANAGEMENT LLC Bought 274.9 Thousand shares of Amphastar Pharmaceuticals...